Literature DB >> 18641858

Seroprevalence of NMO-IgG antibody in Brazilian patients with neuromyelitis optica.

Tarso Adoni1, Angelina Maria Martins Lino, Paulo Eurípedes Marchiori, Fernando Kok, Dagoberto Callegaro.   

Abstract

OBJECTIVE: To determine the seroprevalence of neuromyelitis optica antibody (NMO)-IgG in Brazilian patients with clinical diagnosis of relapsing neuromyelitis optica, also known as Devic's disease.
METHOD: We determined NMO-IgG titers in 28 patients (25 of them females) that fulfilled the 1999 NMO diagnostic criteria proposed by Wingerchuk et al.
RESULTS: NMO-IgG was detected in 18 NMO patients (64.3%).
CONCLUSION: Our results showed that seroprevalence of NMO-IgG in Brazilian NMO patients was similar to the observed in other studies.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18641858     DOI: 10.1590/s0004-282x2008000300001

Source DB:  PubMed          Journal:  Arq Neuropsiquiatr        ISSN: 0004-282X            Impact factor:   1.420


  2 in total

Review 1.  AQP4 antibodies in neuromyelitis optica: diagnostic and pathogenetic relevance.

Authors:  Sven Jarius; Brigitte Wildemann
Journal:  Nat Rev Neurol       Date:  2010-07       Impact factor: 42.937

2.  Neuromyelitis optica-IgG testing in an Indian cohort with neuromyelitis optica and related demyelinating disorders: Our experience.

Authors:  Narayanan Unni; Kavita Barhate; Nisha Ahmad; Malti Ganeshan; Bhim Singhal
Journal:  Ann Indian Acad Neurol       Date:  2013-07       Impact factor: 1.383

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.